Your shopping cart is empty!
Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
Catalog: | HY-19564 |
Brand: | MCE |
CAS: | 729-46-4 |
MDL | MFCD00072237 |
---|---|
Molecular Weight | 324.51 |
Molecular Formula | C10H16N2O2S4 |
SMILES | S=C(N1CCOCC1)SSC(N2CCOCC2)=S |
JX06 is a potent, selective and covalent inhibitor of PDK . JX06 inhibits PDK1 , PDK2 and PDK3 with IC 50 s of 49 nM, 101 nM, and 313 nM, respectively. JX06 inhibits PDK1 activity via covalently binding to a cysteine residue in an irreversible manner. JX06 shows significant antitumor activity [1] .
IC50: 49 nM (PDK1), 101 nM (PDK2), 313 nM (PDK3) [1]
JX06 barely shows inhibitory activity against PDK4 at a concentration of 10 μM
[1]
.
JX06 (1-10 μM; 48 hours) induces cell apoptosis in cancer cells with high ECAR/OCR
[1]
.
JX06 (0-0.6 μM; 72 hours) dose-dependently suppresses the growth of A549 cells
[1]
.
JX06 (0.1-10 μM; 6-24 hours) inhibits PDHA1 phosphorylation in A549 cells in a time- and dose-dependent manner
[1]
.
JX06 (1-10 μM) increases glucose uptake and intracellular ATP level and reduces aerobic glycolysis determined by the lactate production in A549 cells
[1]
.
JX06 (1-10 μM; 24 hours) induces ROS generation in cancer cells with high extracellular acidification rate (ECAR)/ oxygen consumption rate (OCR)
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Apoptosis Analysis [1]
Cell Line: | A549, EBC-1, HT-29 and H460 cells |
Concentration: | 0, 1, 3, 10 μM |
Incubation Time: | 48 hours |
Result: | Induces cell apoptosis in A549 and EBC-1 cells. |
Cell Viability Assay [1]
Cell Line: | A549 cells |
Concentration: | 0, 0.2, 0.4, 0.6 μM |
Incubation Time: | 72 hours |
Result: | Inhibits the viability of A549 cells in a dose dependent manner. |
Western Blot Analysis [1]
Cell Line: | A549 cells |
Concentration: | 0, 0.1, 0.3, 1, 3, 10 μM |
Incubation Time: | 0, 6, 12, 24 hours |
Result: | Decreased PDHA1 phosphorylation at both serine 293 and serine 232 (S293 and S232) in a time- and dose-dependent manner. |
JX06 (40-80 mg/kg; i.p. for 21 days) inhibits tumor growth in vivo [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | A549 subcutaneous xenograft mice [1] |
Dosage: | 40, 80 mg/kg |
Administration: | I.p. injections for 21 days |
Result: |
Reduced tumor weights and 67.5% tumor volume at the dose of 80 mg/kg compared with the vehicle control.
Well tolerated at the administration dose. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 50 mg/mL ( 154.08 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 3.0816 mL | 15.4078 mL | 30.8157 mL |
5 mM | 0.6163 mL | 3.0816 mL | 6.1631 mL |
10 mM | 0.3082 mL | 1.5408 mL | 3.0816 mL |
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.